Cardiac Contractility Modulation (CCM) for Heart Failure (HF) | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Cardiac Contractility Modulation (CCM) for Heart Failure, with an effective date of April 8, 2026. Here's what billing teams need to do.

CMS Cardiac Contractility Modulation coverage policy has been updated as of April 8, 2026. This change affects cardiac device implant billing across electrophysiology, cardiology, and cardiovascular surgery practices. The policy does not list specific CPT or HCPCS codes in the available documentation — more on that below. If your practice bills for CCM device implantation or management in heart failure patients, this update needs your attention before the effective date passes.

---

Quick-Reference Table

Field	Detail Copy
Payer	CMS (Centers for Medicare & Medicaid Services)
Policy	Cardiac Contractility Modulation (CCM) for Heart Failure
Policy Code	N/A
Change Type	Modified
Effective Date	April 8, 2026
Impact Level	High
Specialties Affected	Cardiology, Electrophysiology, Cardiovascular Surgery, Heart Failure Management
Key Action	Audit your CCM device and heart failure billing workflows against updated coverage criteria before submitting claims dated on or after April 8, 2026

---

CMS Cardiac Contractility Modulation Coverage Criteria and Medical Necessity Requirements 2026

CCM is a device-based therapy for heart failure. An implanted pulse generator delivers electrical signals to the heart muscle during the absolute refractory period — not to pace the heart, but to improve contractility. It's distinct from CRT (cardiac resynchronization therapy) and ICD therapy, and CMS has historically treated it differently from both.

The CMS Cardiac Contractility Modulation coverage policy modification effective April 8, 2026, reflects ongoing scrutiny of device-based heart failure therapies. CMS has been tightening medical necessity criteria across advanced cardiac therapies, and this update fits that pattern.

What medical necessity typically requires for CCM under CMS:

CMS medical necessity determinations for CCM have centered on a specific patient profile. Generally, covered patients present with symptomatic heart failure (NYHA Class II or III), reduced ejection fraction (typically LVEF in the range of 25–45%), and are in normal sinus rhythm. Patients must have been on stable, optimized guideline-directed medical therapy (GDMT) before device consideration. That last point — optimized GDMT — is where claims often fail.

CMS also looks at prior treatment history. A patient who hasn't been adequately trialed on beta-blockers, ACE inhibitors or ARBs, and MRAs before CCM implantation will face a medical necessity denial. Document every medication trial in the record before you bill.

Prior authorization requirements for CCM under Medicare have not historically applied uniformly across all Medicare Administrative Contractors. However, some MACs have issued Local Coverage Determinations (LCDs) that impose additional documentation or prior auth steps on top of CMS national policy. Check with your specific MAC before assuming national policy is the only hurdle.

The coverage policy also intersects with the FDA approval status of the device. CMS generally requires that a device hold FDA premarket approval (PMA) for the indicated use. For CCM, that approval is device- and indication-specific. Confirm the device you're implanting carries the correct FDA authorization before submitting claims.

---

CMS Cardiac Contractility Modulation Exclusions and Non-Covered Indications

CMS has not covered CCM for patients who fall outside the approved clinical profile. The following situations typically result in claim denial or non-coverage findings:

Heart failure with preserved ejection fraction (HFpEF): CCM evidence has focused on reduced ejection fraction. Patients with preserved EF have not been supported by the same clinical trial data, and CMS has treated CCM in this population as not medically necessary.

Permanent atrial fibrillation: CCM trials largely excluded patients in permanent AF. CMS coverage policy has reflected that exclusion. If your patient is in permanent AF, CCM reimbursement is not supported under current national policy.

NYHA Class IV: End-stage heart failure patients (Class IV) fall outside the covered indication. These patients are typically candidates for other advanced therapies — LVAD, transplant evaluation — not CCM.

Patients with existing CRT devices: CCM and CRT are not co-indicated. A patient already receiving cardiac resynchronization therapy is generally excluded from CCM coverage. Billing both together will trigger review and likely denial.

Insufficient LVEF documentation: If the chart doesn't include a recent echocardiogram with a documented EF within the covered range, expect a medical necessity denial. A missing or outdated echo is one of the most common reasons CCM claims fail.

---

Coverage Indications at a Glance

Note: The available policy data does not list specific CPT, HCPCS, or ICD-10 codes. See the codes section below for detail.

---

CMS Cardiac Contractility Modulation Billing Guidelines and Action Items 2026

The effective date of April 8, 2026 is not far off. Here's what to do right now.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Cardiac Contractility Modulation Under This Policy

The available policy documentation does not list specific CPT, HCPCS, or ICD-10 codes. This is a gap in the published data, not an oversight in this post.

For CCM device billing, your billing team should work directly with your device vendor's reimbursement support team, your MAC's provider relations contacts, and your coding resources to confirm the correct codes. CCM device implantation typically involves device-specific codes that have evolved as CMS and the AMA have updated their coverage and coding frameworks for cardiac devices.

Do not assume codes from prior CCM claims are still correct. Policy modifications at CMS often accompany coding changes. Verify current codes with your coding team before April 8, 2026.

Codes to Confirm with Your Billing Team

If you're billing CCM and don't have confirmed codes locked down before the effective date of April 8, 2026, stop and get that confirmed first. A claim submitted with the wrong code is a denial you didn't have to earn.

---